Adherence to study medication and visits: Data from the BABY HUG trial

Pediatric Blood and Cancer

Volumn 54, Issue 2, 2010, Pages 260-264

  Thornburg, Courtney D ^a   Rogers, Zora R ^b   Jeng, Michael R ^c   Rana, Sohail R ^d   Iyer, Rathi V ^e   Faughnan, Lane ^f   Hassen, Leann ^g   Marshall, Jennifer ^b   McDonald, Roy P ^h   Wang, Winfred C ^f   Huang, Xiangke ⁱ   Rees, Renée C ⁱ  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOWARD UNIVERSITY   (United States)

^e UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^f ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^g AFLAC   (United States)

^h University of Alabama at Birmingham and Children's Hospital   (United States)

ⁱ Clinical Trials & Surveys Corp   (United States)

Author keywords

Anti sickling agents; Clinical trial; Non adherence; Study retention

Indexed keywords

HYDROXYUREA;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MONITORING; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SICKLE CELL BETA THALASSEMIA; SOCIOECONOMICS; TREATMENT RESPONSE;

ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; CLINICAL TRIALS, PHASE III AS TOPIC; FEMALE; HUMANS; HYDROXYUREA; INFANT; MALE; PATIENT COMPLIANCE; PATIENT DROPOUTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 74849109765     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22324     Document Type: Article

References (20)

1. Elliott V, Morgan S, Day S, et al. Parental health beliefs and compliance with prophylactic penicillin administration in children with sickle cell disease. J Pediatr Hematol Oncol 2001;23:112-116.
2. Day S, Brunson G, Wang W. A successful education program for parents of infants with newly diagnosed sickle cell disease. J Pediatr Nurs 1992;7:52-57.
3. Treadwell MJ, Law AW, Sung J, et al. Barriers to adherence of deferoxamine usage in sickle cell disease. Pediatr Blood Cancer 2005;44:500-507.
4. Olivieri NF,Vichinsky EP. Hydroxyurea in children with sickle cell disease: Impact on splenic function and compliance with therapy. J Pediatr Hematol Oncol 1998;20:26-31.
5. Ware RE, Eggleston B, Redding-Lallinger R, et al. Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood 2002;99:10-14.
6. Zimmerman SA, Schultz WH, Davis JS, et al. Sustained longterm hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood 2004;103:2039-2045.
7. de Montalembert M, Brousse V, Elie C, et al. Long-term hydroxyurea treatment in children with sickle cell disease: Tolerance and clinical outcomes. Haematologica 2006;91:125-128.
8. Bender BG, Ellison MC, Gleason M, et al. Minimizing attrition in a long-term clinical trial of pediatric asthma. Ann Allergy Asthma Immunol 2003;91:168-176.
9. Bender BG, Ikle DN, DuHamel T, et al. Retention of asthmatic patients in a longitudinal clinical trial. J Allergy Clin Immunol 1997;99:197-203.
10. Strunk RC, Bender B, Young DA, et al. Predictors of protocol adherence in a pediatric asthma clinical trial. J Allergy Clin Immunol 2002;110:596-602.
11. Karlson CW, Rapoff MA. Attrition in randomized controlled trials for pediatric chronic conditions. J Pediatr Psychol 2008; 34:782-793.
12. Driscoll KA, Killian M, Johnson SB, et al. Predictors of study completion and withdrawal in a randomized clinical trial of a pediatric diabetes adherence intervention. Contemp Clin Trials 2009. doi:10.1016/j.cct.2009.01.008
13. Janus M, Goldberg S. Factors influencing family participation in a longitudinal study: Comparison of pediatric and healthy samples. J Pediatr Psychol 1997;22:245-262.
14. Riekert KA, Drotar D.Whoparticipates in research on adherence to treatment in insulin-dependent diabetes mellitus? Implications and recommendations for research. J Pediatr Psychol 1999;24:253-258.
15. Moser DK, Dracup K, Doering LV. Factors differentiating dropouts from completers in a longitudinal, multicenter clinical trial. Nurs Res 2000;49:109-116.
16. Wang WC, Pavlakis SG, Helton KJ, et al. MRI abnormalities of the brain in one-year-old children with sickle cell anemia. Pediatr Blood Cancer 2008;51:643-646.
17. Frush KS, Luo X, Hutchinson P, et al. Evaluation of a method to reduce over-the-counter medication dosing error. Arch Pediatr Adolesc Med 2004;158:620-624.
18. Li SF, Lacher B, Crain EF. Acetaminophen and ibuprofen dosing by parents. Pediatr Emerg Care 2000;16:394-397.
19. Yin HS, Dreyer BP, van Schaick L, et al. Randomized controlled trial of a pictogram-based intervention to reduce liquid medication dosing errors and improve adherence among caregivers of young children. Arch Pediatr Adolesc Med 2008;162:814-822.
20. Jayaraman S, Rieder MJ, Matsui DM. Compliance assessment in drug trials: Has there been improvement in two decades? Can J Clin Pharmacol 2005;12:e251-e253.